A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards, taking children out of school and keeping parents off work.

A new trial that aims to protect against norovirus, a highly contagious stomach bug that causes vomiting and diarrhoea, is set to be trialled on 25,000 people. Norovirus, commonly referred to as the “winter vomiting bug”, affects people of all ages and has had significant societal and healthcare impacts.

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.

A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards,

The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna. View on euronews

A vaccine to guard against the winter vomiting bug norovirus is set for a year-long groundbreaking NHS trial after early results showed it creates a “strong immune response”. It is hoped an effective norovirus vaccine,